[ad_1] Lisata jumps on FDA orphan drug status for bile duct cancer drug [ad_2] Source: Seekingalpha
Browsing: Healthcare
[ad_1] Ascendis raised to outperform by Oppenheimer ahead of drug launch [ad_2] Source: Seekingalpha
[ad_1] Vor Bio stock rallies post-market on trem-cel study data [ad_2] Source: Seekingalpha
[ad_1] aTyr started at buy by Jefferies, citing efzofitimod potential [ad_2] Source: Seekingalpha
[ad_1] Kits Eyecare announces $10.15M secondary offering [ad_2] Source: Seekingalpha
[ad_1] Fanhua and Shanghai Biotecan Pharmaceuticals enters into cooperation agreement [ad_2] Source: Seekingalpha
[ad_1] Travere gains on full FDA approval for kidney drug Filspari [ad_2] Source: Seekingalpha
[ad_1] GSK’s Nucala succeeds in late-stage study for lung dysfunction, COPD [ad_2] Source: Seekingalpha
[ad_1] Axogen completes marketing submission for Avance Nerve Graft [ad_2] Source: Seekingalpha
[ad_1] Organon downgraded, Amneal upgraded as J.P. Morgan reviews specialty pharma [ad_2] Source: Seekingalpha
